Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Grape King Bio
Taoyuan City, Taiwan
- Ownership
- Private
- Employees
- ~501
- Development stage
- Other
01
Overview
Grape King Bio markets multiple TFDA-certified health food products (including probiotics and mushroom mycelium bioactives) and is Taiwan’s largest fermentation manufacturer for these products, with some products supported by national/international quality awards. No traditional drug clinical trial data publicly available; focus is on functional foods with clinically validated or TFDA-recognized health benefits.
- Therapeutic areas
- NephrologyImmunologyOphthalmologyEndocrinologyWomen's HealthGastroenterologyNeurologyPulmonologyDermatology
- Modalities
- ProbioticsLive biotherapeutic product therapySmall moleculeMicrobial therapyProteinBiologic
- Industry
- Non-Drug Biotech
Beyond the preview
Go deeper on Grape King Bio.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Grape King Bio.